Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study

Immunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis (JIA) or inflammatory bowel disease (IBD). We determined immunogenicity of a MenACWY-TT vaccine in JIA and IBD patients at adolescent age and...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 41; no. 25; pp. 3782 - 3789
Main Authors Ohm, Milou, van Straalen, Joeri W., Zijlstra, Marieke, de Joode-Smink, Gerrie, Sellies, Anne Jasmijn, Swart, Joost F., Vastert, Sebastiaan J., van Montfrans, Joris M., Bartels, Marije, van Royen-Kerkhof, Annet, Wildenbeest, Joanne G., Lindemans, Caroline A., Wolters, Victorien M., Wennink, Roos A.W., de Boer, Joke H., Knol, Mirjam J., Heijstek, Marloes W., Sanders, Elisabeth A.M., Verduyn-Lunel, Frans M., Berbers, Guy A.M., Wulffraat, Nico M., Jansen, Marc H.A.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 07.06.2023
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Immunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis (JIA) or inflammatory bowel disease (IBD). We determined immunogenicity of a MenACWY-TT vaccine in JIA and IBD patients at adolescent age and compared results to data from aged-matched healthy controls (HCs). We performed a prospective observational cohort study in JIA and IBD patients (14–18 years old), who received a MenACWY vaccination during a nationwide catch-up campaign (2018–2019) in the Netherlands. Primary aim was to compare MenACWY polysaccharide-specific serum IgG geometric mean concentrations (GMCs) in patients with HCs and secondary between patients with or without anti-TNF therapy. GMCs were determined before and 3–6, 12, and 24 months postvaccination and compared with data from HCs at baseline and 12 months postvaccination. Serum bactericidal antibody (SBA) titers were determined in a subset of patients at 12 months postvaccination. We included 226 JIA and IBD patients (66 % and 34 % respectively). GMCs were lower for MenA and MenW (GMC ratio 0·24 [0·17-0·34] and 0·16 [0·10-0·26] respectively, p < 0·01) in patients compared to HCs at 12 months postvaccination. Anti-TNF users had lower MenACWY GMCs postvaccination compared with those without anti-TNF (p < 0·01). The proportion protected (SBA ≥ 8) for MenW was reduced in anti-TNF users (76 % versus 92 % in non-anti-TNF and 100 % in HCs, p < 0.01). The MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.
AbstractList Immunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis (JIA) or inflammatory bowel disease (IBD). We determined immunogenicity of a MenACWY-TT vaccine in JIA and IBD patients at adolescent age and compared results to data from aged-matched healthy controls (HCs). We performed a prospective observational cohort study in JIA and IBD patients (14-18 years old), who received a MenACWY vaccination during a nationwide catch-up campaign (2018-2019) in the Netherlands. Primary aim was to compare MenACWY polysaccharide-specific serum IgG geometric mean concentrations (GMCs) in patients with HCs and secondary between patients with or without anti-TNF therapy. GMCs were determined before and 3-6, 12, and 24 months postvaccination and compared with data from HCs at baseline and 12 months postvaccination. Serum bactericidal antibody (SBA) titers were determined in a subset of patients at 12 months postvaccination. We included 226 JIA and IBD patients (66 % and 34 % respectively). GMCs were lower for MenA and MenW (GMC ratio 0·24 [0·17-0·34] and 0·16 [0·10-0·26] respectively, p < 0·01) in patients compared to HCs at 12 months postvaccination. Anti-TNF users had lower MenACWY GMCs postvaccination compared with those without anti-TNF (p < 0·01). The proportion protected (SBA ≥ 8) for MenW was reduced in anti-TNF users (76 % versus 92 % in non-anti-TNF and 100 % in HCs, p < 0.01). The MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.
BackgroundImmunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis (JIA) or inflammatory bowel disease (IBD). We determined immunogenicity of a MenACWY-TT vaccine in JIA and IBD patients at adolescent age and compared results to data from aged-matched healthy controls (HCs).MethodsWe performed a prospective observational cohort study in JIA and IBD patients (14–18 years old), who received a MenACWY vaccination during a nationwide catch-up campaign (2018–2019) in the Netherlands. Primary aim was to compare MenACWY polysaccharide-specific serum IgG geometric mean concentrations (GMCs) in patients with HCs and secondary between patients with or without anti-TNF therapy. GMCs were determined before and 3–6, 12, and 24 months postvaccination and compared with data from HCs at baseline and 12 months postvaccination. Serum bactericidal antibody (SBA) titers were determined in a subset of patients at 12 months postvaccination.ResultsWe included 226 JIA and IBD patients (66 % and 34 % respectively). GMCs were lower for MenA and MenW (GMC ratio 0·24 [0·17-0·34] and 0·16 [0·10-0·26] respectively, p < 0·01) in patients compared to HCs at 12 months postvaccination. Anti-TNF users had lower MenACWY GMCs postvaccination compared with those without anti-TNF (p < 0·01). The proportion protected (SBA ≥ 8) for MenW was reduced in anti-TNF users (76 % versus 92 % in non-anti-TNF and 100 % in HCs, p < 0.01).ConclusionThe MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.
Immunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis (JIA) or inflammatory bowel disease (IBD). We determined immunogenicity of a MenACWY-TT vaccine in JIA and IBD patients at adolescent age and compared results to data from aged-matched healthy controls (HCs).BACKGROUNDImmunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis (JIA) or inflammatory bowel disease (IBD). We determined immunogenicity of a MenACWY-TT vaccine in JIA and IBD patients at adolescent age and compared results to data from aged-matched healthy controls (HCs).We performed a prospective observational cohort study in JIA and IBD patients (14-18 years old), who received a MenACWY vaccination during a nationwide catch-up campaign (2018-2019) in the Netherlands. Primary aim was to compare MenACWY polysaccharide-specific serum IgG geometric mean concentrations (GMCs) in patients with HCs and secondary between patients with or without anti-TNF therapy. GMCs were determined before and 3-6, 12, and 24 months postvaccination and compared with data from HCs at baseline and 12 months postvaccination. Serum bactericidal antibody (SBA) titers were determined in a subset of patients at 12 months postvaccination.METHODSWe performed a prospective observational cohort study in JIA and IBD patients (14-18 years old), who received a MenACWY vaccination during a nationwide catch-up campaign (2018-2019) in the Netherlands. Primary aim was to compare MenACWY polysaccharide-specific serum IgG geometric mean concentrations (GMCs) in patients with HCs and secondary between patients with or without anti-TNF therapy. GMCs were determined before and 3-6, 12, and 24 months postvaccination and compared with data from HCs at baseline and 12 months postvaccination. Serum bactericidal antibody (SBA) titers were determined in a subset of patients at 12 months postvaccination.We included 226 JIA and IBD patients (66 % and 34 % respectively). GMCs were lower for MenA and MenW (GMC ratio 0·24 [0·17-0·34] and 0·16 [0·10-0·26] respectively, p < 0·01) in patients compared to HCs at 12 months postvaccination. Anti-TNF users had lower MenACWY GMCs postvaccination compared with those without anti-TNF (p < 0·01). The proportion protected (SBA ≥ 8) for MenW was reduced in anti-TNF users (76 % versus 92 % in non-anti-TNF and 100 % in HCs, p < 0.01).RESULTSWe included 226 JIA and IBD patients (66 % and 34 % respectively). GMCs were lower for MenA and MenW (GMC ratio 0·24 [0·17-0·34] and 0·16 [0·10-0·26] respectively, p < 0·01) in patients compared to HCs at 12 months postvaccination. Anti-TNF users had lower MenACWY GMCs postvaccination compared with those without anti-TNF (p < 0·01). The proportion protected (SBA ≥ 8) for MenW was reduced in anti-TNF users (76 % versus 92 % in non-anti-TNF and 100 % in HCs, p < 0.01).The MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.CONCLUSIONThe MenACWY conjugate vaccine was immunogenic in the vast majority of JIA and IBD patients at adolescent age, but seroprotection was lower in patients using anti-TNF agents. Therefore, an extra booster MenACWY vaccination should be considered.
Author Verduyn-Lunel, Frans M.
Sanders, Elisabeth A.M.
Vastert, Sebastiaan J.
van Montfrans, Joris M.
Knol, Mirjam J.
van Royen-Kerkhof, Annet
de Joode-Smink, Gerrie
van Straalen, Joeri W.
Sellies, Anne Jasmijn
de Boer, Joke H.
Wildenbeest, Joanne G.
Wulffraat, Nico M.
Bartels, Marije
Lindemans, Caroline A.
Wolters, Victorien M.
Wennink, Roos A.W.
Jansen, Marc H.A.
Swart, Joost F.
Heijstek, Marloes W.
Berbers, Guy A.M.
Ohm, Milou
Zijlstra, Marieke
Author_xml – sequence: 1
  givenname: Milou
  surname: Ohm
  fullname: Ohm, Milou
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
– sequence: 2
  givenname: Joeri W.
  surname: van Straalen
  fullname: van Straalen, Joeri W.
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 3
  givenname: Marieke
  surname: Zijlstra
  fullname: Zijlstra, Marieke
  organization: Department of Pediatric Gastroenterology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 4
  givenname: Gerrie
  surname: de Joode-Smink
  fullname: de Joode-Smink, Gerrie
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 5
  givenname: Anne Jasmijn
  surname: Sellies
  fullname: Sellies, Anne Jasmijn
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 6
  givenname: Joost F.
  surname: Swart
  fullname: Swart, Joost F.
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 7
  givenname: Sebastiaan J.
  surname: Vastert
  fullname: Vastert, Sebastiaan J.
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 8
  givenname: Joris M.
  surname: van Montfrans
  fullname: van Montfrans, Joris M.
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 9
  givenname: Marije
  surname: Bartels
  fullname: Bartels, Marije
  organization: Department of Pediatric Hematology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 10
  givenname: Annet
  surname: van Royen-Kerkhof
  fullname: van Royen-Kerkhof, Annet
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 11
  givenname: Joanne G.
  surname: Wildenbeest
  fullname: Wildenbeest, Joanne G.
  organization: Department of Pediatric Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 12
  givenname: Caroline A.
  surname: Lindemans
  fullname: Lindemans, Caroline A.
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 13
  givenname: Victorien M.
  surname: Wolters
  fullname: Wolters, Victorien M.
  organization: Department of Pediatric Gastroenterology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 14
  givenname: Roos A.W.
  surname: Wennink
  fullname: Wennink, Roos A.W.
  organization: Department of Ophthalmology, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 15
  givenname: Joke H.
  surname: de Boer
  fullname: de Boer, Joke H.
  organization: Department of Ophthalmology, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 16
  givenname: Mirjam J.
  surname: Knol
  fullname: Knol, Mirjam J.
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
– sequence: 17
  givenname: Marloes W.
  surname: Heijstek
  fullname: Heijstek, Marloes W.
  organization: Department of Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 18
  givenname: Elisabeth A.M.
  surname: Sanders
  fullname: Sanders, Elisabeth A.M.
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
– sequence: 19
  givenname: Frans M.
  surname: Verduyn-Lunel
  fullname: Verduyn-Lunel, Frans M.
  organization: Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 20
  givenname: Guy A.M.
  surname: Berbers
  fullname: Berbers, Guy A.M.
  organization: Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
– sequence: 21
  givenname: Nico M.
  surname: Wulffraat
  fullname: Wulffraat, Nico M.
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 22
  givenname: Marc H.A.
  surname: Jansen
  fullname: Jansen, Marc H.A.
  email: m.h.a.jansen@umcutrecht.nl
  organization: Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37198018$$D View this record in MEDLINE/PubMed
BookMark eNqFkUuP0zAUhS00iOkM_ASQJTZsUvzIw2GDqoqXNIgNCFhZtnPTOkrsYjsZ9afx73BpYcGGlb34zr3nnnODrpx3gNBTStaU0PrlsF6UMdbBmhHG16Rck6p-gFZUNLxgFRVXaEVYXRYlJd-u0U2MAyGk4rR9hK55Q1tBqFihnx_BWbfzxhujRrzZfv2OjXfDvFMJ8GUFttM0O7_LqLHpiJXrcFQ95K91WHV-hGjApYjvbdrjYV4yOWZZZ_1Bpb01WIW0DzbZ-FtsXT-qaVLJhyPW_h5G3NkIKsIrvMGH4OMBTLILYK8jhEUl6122Z_zeh4RjmrvjY_SwV2OEJ5f3Fn15--bz9n1x9-ndh-3mrjC85aloteJK64rwxijBmNINGNE2rW4EVC2ICnTHe94w1pW6Jr3grO3rWhFOoNSE36IX57nZ1o8ZYpKTzdeOo3Lg5yiZoBUrG9E0GX3-Dzr4OWTjJ4qRtq5ydZmqzpTJd8YAvTwEO6lwlJTIU7dykJfg5albSUqZu826Z5fps56g-6v6U2YGXp8ByHEsFoKMxoIz0NmQ45Sdt_9Z8Qt9XL8D
CitedBy_id crossref_primary_10_1080_14760584_2023_2245467
crossref_primary_10_1007_s00431_023_05080_3
crossref_primary_10_1136_rmdopen_2023_002985
crossref_primary_10_1186_s12969_023_00846_3
crossref_primary_10_3390_microorganisms12010030
Cites_doi 10.1002/sim.4067
10.1038/nrrheum.2013.95
10.1002/ibd.21649
10.2807/1560-7917.ES.2018.23.16.18-00158
10.1016/j.vaccine.2017.06.053
10.1016/j.cmi.2017.12.025
10.1136/annrheumdis-2012-202031
10.1016/j.autrev.2011.08.010
10.1053/j.gastro.2007.05.029
10.1016/S0140-6736(07)60363-8
10.4049/jimmunol.176.4.2617
10.1002/art.22399
10.1016/j.vaccine.2005.01.051
10.1097/INF.0000000000000931
10.1136/annrheumdis-2022-222574
10.1136/annrheumdis-2012-202561
10.1038/nri2494
10.1177/1536867X0900900208
10.1128/cdli.4.2.156-167.1997
10.1186/s13075-018-1725-6
10.1128/CVI.00364-08
10.1001/jamapediatrics.2015.1982
10.1007/s11908-011-0183-y
10.1016/j.vaccine.2017.06.007
10.1542/peds.2016-1209
ContentType Journal Article
Copyright 2023
Copyright © 2023. Published by Elsevier Ltd.
Copyright Elsevier Limited Jun 7, 2023
Copyright_xml – notice: 2023
– notice: Copyright © 2023. Published by Elsevier Ltd.
– notice: Copyright Elsevier Limited Jun 7, 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1016/j.vaccine.2023.04.056
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (Proquest)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni Edition)
Health Management Database (Proquest)
PML(ProQuest Medical Library)
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Research Library Prep

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
Public Health
EISSN 1873-2518
EndPage 3789
ExternalDocumentID 10_1016_j_vaccine_2023_04_056
37198018
S0264410X23004802
Genre Journal Article
Observational Study
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ACDAQ
ACGFO
ACGFS
ACIUM
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AEXOQ
AFCTW
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGGSO
AGUBO
AGYEJ
AHMBA
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQUVI
AXJTR
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HMCUK
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
PSQYO
Q38
RIG
ROL
RPZ
SAB
SCC
SDF
SDG
SDP
SES
SNL
SPCBC
SSH
SSI
SSZ
T5K
UKHRP
UV1
WH7
WOW
Z5R
~G-
AAXKI
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
.GJ
29Q
3V.
AAQXK
AAYXX
ABXDB
ACRPL
ADMUD
ADNMO
ADVLN
AGHFR
AHHHB
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
G-2
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
HZ~
R2-
SAE
SEW
SIN
SVS
WUQ
XPP
ZGI
ZXP
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c393t-9ba3abb5037ca822ab7ec8979b78e59e85ebd3f3722d4b60f8329f66a030e4b03
IEDL.DBID AIKHN
ISSN 0264-410X
1873-2518
IngestDate Thu Dec 05 22:31:32 EST 2024
Thu Nov 07 06:20:08 EST 2024
Fri Dec 06 08:51:05 EST 2024
Sat Nov 02 12:24:03 EDT 2024
Sat Aug 03 15:33:24 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 25
Keywords Inflammatory bowel disease
Anti-TNF agents
MenACWY vaccination
Immunogenicity
Immunocompromised
Safety
Adolescents
Juvenile idiopathic arthritis
Biologicals
Language English
License Copyright © 2023. Published by Elsevier Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c393t-9ba3abb5037ca822ab7ec8979b78e59e85ebd3f3722d4b60f8329f66a030e4b03
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 37198018
PQID 2820965101
PQPubID 105530
PageCount 8
ParticipantIDs proquest_miscellaneous_2815247877
proquest_journals_2820965101
crossref_primary_10_1016_j_vaccine_2023_04_056
pubmed_primary_37198018
elsevier_sciencedirect_doi_10_1016_j_vaccine_2023_04_056
PublicationCentury 2000
PublicationDate 2023-06-07
PublicationDateYYYYMMDD 2023-06-07
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-07
  day: 07
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Ravelli, Martini (b0010) 2007; 369
van Lier, al. e. Vaccinatiegraad Rijksvaccinatieprogramma Nederland; Verslagjaar 2006-2008, 2008.
Pollard, Perrett, Beverley (b0120) 2009; 9
Turner, Griffiths, Walters (b0085) 2012; 18
de Voer, Schepp, Versteegh, van der Klis, Berbers (b0065) 2009; 16
Turner, Otley, Mack, Hyams, de Bruijne, Uusoue (b0090) 2007; 133
Molenberghs, Verbeke (b0095) 2000
Stoof, Heijstek, Sijssens, van der Klis, Sanders, Teunis (b0110) 2014; 73
Johnston, Essink, Kirstein, Forleo-Neto, Percell, Han (b0145) 2016; 35
Keystone, Ware (b0020) 2010; 85
Reich, Wasan, Farraye (b0030) 2016; 12
Zonneveld-Huijssoon, Ronaghy, Van Rossum, Rijkers, Van Der Klis, Sanders (b0045) 2007; 56
Rosen, Dhawan, Saeed (b0015) 2015; 169
van Ravenhorst, van der Klis, van Rooijen, Knol, Stoof, Sanders (b0055) 2017; 35
Borrow, Balmer, Miller (b0070) 2005; 23
White, Royston, Wood (b0100) 2011; 30
Davignon, Rauwel, Degboé, Constantin, Boyer, Kruglov (b0125) 2018; 20
Heijstek, Ott de Bruin, Borrow, van der Klis, Koné-Paut, Fasth (b0150) 2011; 11
Mcerlane, Beresford, Baildam, Chieng, Davidson, Foster (b0080) 2013; 72
Baddley, Cantini, Goletti, Gómez-Reino, Mylonakis, San-Juan (b0115) 2018; 24
Silva, Aikawa, Bonfa (b0025) 2013; 9
Knol, Ruijs, Antonise-Kamp, de Melker, van der Ende (b0050) 2018; 23
van Ravenhorst, van der Klis, van Rooijen, Sanders, Berbers (b0060) 2017; 35
Jansen, Rondaan, Legger, Minden, Uziel, Toplak (b0035) 2021; 10
Jansen, Rondaan, Legger, Minden, Uziel, Toplak (b0040) 2023; 82
Danese, Sans, Scaldaferri (b0130) 2006; 176
Visser (b0140) 2011; 13
Chatfield, Mander (b0105) 2009; 9
Davies, DISEASES (b0005) 2016; 138
Maslanka, Gheesling, Libutti, Donaldson, Harakeh, Dykes (b0075) 1997; 4
Reich (10.1016/j.vaccine.2023.04.056_b0030) 2016; 12
Johnston (10.1016/j.vaccine.2023.04.056_b0145) 2016; 35
van Ravenhorst (10.1016/j.vaccine.2023.04.056_b0060) 2017; 35
Silva (10.1016/j.vaccine.2023.04.056_b0025) 2013; 9
Zonneveld-Huijssoon (10.1016/j.vaccine.2023.04.056_b0045) 2007; 56
Danese (10.1016/j.vaccine.2023.04.056_b0130) 2006; 176
Jansen (10.1016/j.vaccine.2023.04.056_b0040) 2023; 82
Knol (10.1016/j.vaccine.2023.04.056_b0050) 2018; 23
Maslanka (10.1016/j.vaccine.2023.04.056_b0075) 1997; 4
Mcerlane (10.1016/j.vaccine.2023.04.056_b0080) 2013; 72
van Ravenhorst (10.1016/j.vaccine.2023.04.056_b0055) 2017; 35
Pollard (10.1016/j.vaccine.2023.04.056_b0120) 2009; 9
Chatfield (10.1016/j.vaccine.2023.04.056_b0105) 2009; 9
Davies (10.1016/j.vaccine.2023.04.056_b0005) 2016; 138
Turner (10.1016/j.vaccine.2023.04.056_b0085) 2012; 18
Rosen (10.1016/j.vaccine.2023.04.056_b0015) 2015; 169
White (10.1016/j.vaccine.2023.04.056_b0100) 2011; 30
Davignon (10.1016/j.vaccine.2023.04.056_b0125) 2018; 20
Baddley (10.1016/j.vaccine.2023.04.056_b0115) 2018; 24
Molenberghs (10.1016/j.vaccine.2023.04.056_b0095) 2000
Heijstek (10.1016/j.vaccine.2023.04.056_b0150) 2011; 11
Ravelli (10.1016/j.vaccine.2023.04.056_b0010) 2007; 369
Turner (10.1016/j.vaccine.2023.04.056_b0090) 2007; 133
Keystone (10.1016/j.vaccine.2023.04.056_b0020) 2010; 85
Jansen (10.1016/j.vaccine.2023.04.056_b0035) 2021; 10
de Voer (10.1016/j.vaccine.2023.04.056_b0065) 2009; 16
10.1016/j.vaccine.2023.04.056_b0135
Borrow (10.1016/j.vaccine.2023.04.056_b0070) 2005; 23
Stoof (10.1016/j.vaccine.2023.04.056_b0110) 2014; 73
Visser (10.1016/j.vaccine.2023.04.056_b0140) 2011; 13
References_xml – volume: 24
  start-page: S10
  year: 2018
  end-page: S20
  ident: b0115
  article-title: ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
  publication-title: Clin Microbiol Infect
  contributor:
    fullname: San-Juan
– volume: 169
  start-page: 1053
  year: 2015
  end-page: 1060
  ident: b0015
  article-title: Inflammatory bowel disease in children and adolescents
  publication-title: JAMA Pediatr
  contributor:
    fullname: Saeed
– volume: 23
  start-page: 2222
  year: 2005
  end-page: 2227
  ident: b0070
  article-title: Meningococcal surrogates of protection–serum bactericidal antibody activity
  publication-title: Vaccine
  contributor:
    fullname: Miller
– volume: 72
  start-page: 1983
  year: 2013
  end-page: 1988
  ident: b0080
  article-title: Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Foster
– volume: 9
  start-page: 299
  year: 2009
  end-page: 305
  ident: b0105
  article-title: The Skillings-Mack test (Friedman test when there are missing data)
  publication-title: Stata J
  contributor:
    fullname: Mander
– volume: 133
  start-page: 423
  year: 2007
  end-page: 432
  ident: b0090
  article-title: Development, validation, and evaluation of a pediatric ulcerative colitis activity index: A Prospective Multicenter Study
  publication-title: Gastroenterology
  contributor:
    fullname: Uusoue
– year: 2000
  ident: b0095
  article-title: Linear mixed models for longitudinal data
  contributor:
    fullname: Verbeke
– volume: 11
  start-page: 112
  year: 2011
  end-page: 122
  ident: b0150
  article-title: Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations
  publication-title: Autoimmun Rev
  contributor:
    fullname: Fasth
– volume: 9
  start-page: 532
  year: 2013
  end-page: 543
  ident: b0025
  article-title: Vaccinations in juvenile chronic inflammatory diseases: an update
  publication-title: Nat Rev Rheumatol
  contributor:
    fullname: Bonfa
– volume: 82
  start-page: 35
  year: 2023
  end-page: 47
  ident: b0040
  article-title: EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Toplak
– volume: 18
  start-page: 55
  year: 2012
  end-page: 62
  ident: b0085
  article-title: Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions
  publication-title: Inflamm Bowel Dis
  contributor:
    fullname: Walters
– volume: 10
  year: 2021
  ident: b0035
  article-title: Update of the EULAR/PRES recommendations
  publication-title: Front Pediatr
  contributor:
    fullname: Toplak
– volume: 16
  start-page: 433
  year: 2009
  end-page: 436
  ident: b0065
  article-title: Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay
  publication-title: Clin Vaccine Immunol: CVI
  contributor:
    fullname: Berbers
– volume: 176
  start-page: 2617
  year: 2006
  end-page: 2624
  ident: b0130
  article-title: TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease
  publication-title: J Immunol
  contributor:
    fullname: Scaldaferri
– volume: 20
  year: 2018
  ident: b0125
  article-title: Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
  publication-title: Arthritis Res Ther
  contributor:
    fullname: Kruglov
– volume: 56
  start-page: 639
  year: 2007
  end-page: 646
  ident: b0045
  article-title: Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis
  publication-title: Arthritis Rheum
  contributor:
    fullname: Sanders
– volume: 23
  start-page: 18
  year: 2018
  end-page: 00158
  ident: b0050
  article-title: Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
  publication-title: Eurosurveillance
  contributor:
    fullname: van der Ende
– volume: 35
  start-page: 4745
  year: 2017
  end-page: 4752
  ident: b0055
  article-title: Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial
  publication-title: Vaccine
  contributor:
    fullname: Sanders
– volume: 35
  start-page: 4753
  year: 2017
  end-page: 4760
  ident: b0060
  article-title: Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination
  publication-title: Vaccine
  contributor:
    fullname: Berbers
– volume: 9
  start-page: 213
  year: 2009
  end-page: 220
  ident: b0120
  article-title: Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
  publication-title: Nat Rev Immunol
  contributor:
    fullname: Beverley
– volume: 73
  start-page: 728
  year: 2014
  end-page: 734
  ident: b0110
  article-title: Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study
  publication-title: Ann Rheum Dis
  contributor:
    fullname: Teunis
– volume: 35
  start-page: e19
  year: 2016
  end-page: e27
  ident: b0145
  article-title: Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age
  publication-title: Pediatr Infect Dis J
  contributor:
    fullname: Han
– volume: 13
  start-page: 243
  year: 2011
  end-page: 247
  ident: b0140
  article-title: TNF-α Antagonists and Immunization
  publication-title: Curr Infect Dis Rep
  contributor:
    fullname: Visser
– volume: 369
  start-page: 767
  year: 2007
  end-page: 778
  ident: b0010
  article-title: Juvenile idiopathic arthritis
  publication-title: Lancet
  contributor:
    fullname: Martini
– volume: 138
  year: 2016
  ident: b0005
  article-title: Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children
  publication-title: Pediatrics
  contributor:
    fullname: DISEASES
– volume: 4
  start-page: 156
  year: 1997
  end-page: 167
  ident: b0075
  article-title: Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group
  publication-title: Clin Diagn Lab Immunol
  contributor:
    fullname: Dykes
– volume: 85
  start-page: 27
  year: 2010
  end-page: 39
  ident: b0020
  article-title: Tumor necrosis factor and anti-tumor necrosis factor therapies
  publication-title: J Rheumatol
  contributor:
    fullname: Ware
– volume: 30
  start-page: 377
  year: 2011
  end-page: 399
  ident: b0100
  article-title: Multiple imputation using chained equations: Issues and guidance for practice
  publication-title: Stat Med
  contributor:
    fullname: Wood
– volume: 12
  start-page: 540
  year: 2016
  end-page: 546
  ident: b0030
  article-title: Vaccinating patients with inflammatory bowel disease
  publication-title: Gastroenterol Hepatol (N Y)
  contributor:
    fullname: Farraye
– volume: 30
  start-page: 377
  issue: 4
  year: 2011
  ident: 10.1016/j.vaccine.2023.04.056_b0100
  article-title: Multiple imputation using chained equations: Issues and guidance for practice
  publication-title: Stat Med
  doi: 10.1002/sim.4067
  contributor:
    fullname: White
– volume: 9
  start-page: 532
  issue: 9
  year: 2013
  ident: 10.1016/j.vaccine.2023.04.056_b0025
  article-title: Vaccinations in juvenile chronic inflammatory diseases: an update
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.95
  contributor:
    fullname: Silva
– volume: 18
  start-page: 55
  issue: 1
  year: 2012
  ident: 10.1016/j.vaccine.2023.04.056_b0085
  article-title: Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.21649
  contributor:
    fullname: Turner
– volume: 10
  year: 2021
  ident: 10.1016/j.vaccine.2023.04.056_b0035
  article-title: Update of the EULAR/PRES recommendations
  publication-title: Front Pediatr
  contributor:
    fullname: Jansen
– volume: 23
  start-page: 18
  issue: 16
  year: 2018
  ident: 10.1016/j.vaccine.2023.04.056_b0050
  article-title: Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2018.23.16.18-00158
  contributor:
    fullname: Knol
– volume: 35
  start-page: 4745
  issue: 36
  year: 2017
  ident: 10.1016/j.vaccine.2023.04.056_b0055
  article-title: Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2017.06.053
  contributor:
    fullname: van Ravenhorst
– year: 2000
  ident: 10.1016/j.vaccine.2023.04.056_b0095
  contributor:
    fullname: Molenberghs
– volume: 24
  start-page: S10
  year: 2018
  ident: 10.1016/j.vaccine.2023.04.056_b0115
  article-title: ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2017.12.025
  contributor:
    fullname: Baddley
– volume: 85
  start-page: 27
  year: 2010
  ident: 10.1016/j.vaccine.2023.04.056_b0020
  article-title: Tumor necrosis factor and anti-tumor necrosis factor therapies
  publication-title: J Rheumatol
  contributor:
    fullname: Keystone
– volume: 72
  start-page: 1983
  issue: 12
  year: 2013
  ident: 10.1016/j.vaccine.2023.04.056_b0080
  article-title: Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202031
  contributor:
    fullname: Mcerlane
– volume: 11
  start-page: 112
  issue: 2
  year: 2011
  ident: 10.1016/j.vaccine.2023.04.056_b0150
  article-title: Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2011.08.010
  contributor:
    fullname: Heijstek
– volume: 133
  start-page: 423
  issue: 2
  year: 2007
  ident: 10.1016/j.vaccine.2023.04.056_b0090
  article-title: Development, validation, and evaluation of a pediatric ulcerative colitis activity index: A Prospective Multicenter Study
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.05.029
  contributor:
    fullname: Turner
– volume: 369
  start-page: 767
  issue: 9563
  year: 2007
  ident: 10.1016/j.vaccine.2023.04.056_b0010
  article-title: Juvenile idiopathic arthritis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60363-8
  contributor:
    fullname: Ravelli
– volume: 176
  start-page: 2617
  issue: 4
  year: 2006
  ident: 10.1016/j.vaccine.2023.04.056_b0130
  article-title: TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.4.2617
  contributor:
    fullname: Danese
– volume: 56
  start-page: 639
  issue: 2
  year: 2007
  ident: 10.1016/j.vaccine.2023.04.056_b0045
  article-title: Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22399
  contributor:
    fullname: Zonneveld-Huijssoon
– volume: 23
  start-page: 2222
  issue: 17–18
  year: 2005
  ident: 10.1016/j.vaccine.2023.04.056_b0070
  article-title: Meningococcal surrogates of protection–serum bactericidal antibody activity
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.01.051
  contributor:
    fullname: Borrow
– volume: 35
  start-page: e19
  issue: 1
  year: 2016
  ident: 10.1016/j.vaccine.2023.04.056_b0145
  article-title: Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000000931
  contributor:
    fullname: Johnston
– volume: 82
  start-page: 35
  issue: 1
  year: 2023
  ident: 10.1016/j.vaccine.2023.04.056_b0040
  article-title: EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2022-222574
  contributor:
    fullname: Jansen
– volume: 73
  start-page: 728
  issue: 4
  year: 2014
  ident: 10.1016/j.vaccine.2023.04.056_b0110
  article-title: Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-202561
  contributor:
    fullname: Stoof
– volume: 9
  start-page: 213
  issue: 3
  year: 2009
  ident: 10.1016/j.vaccine.2023.04.056_b0120
  article-title: Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2494
  contributor:
    fullname: Pollard
– volume: 9
  start-page: 299
  issue: 2
  year: 2009
  ident: 10.1016/j.vaccine.2023.04.056_b0105
  article-title: The Skillings-Mack test (Friedman test when there are missing data)
  publication-title: Stata J
  doi: 10.1177/1536867X0900900208
  contributor:
    fullname: Chatfield
– volume: 4
  start-page: 156
  issue: 2
  year: 1997
  ident: 10.1016/j.vaccine.2023.04.056_b0075
  article-title: Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/cdli.4.2.156-167.1997
  contributor:
    fullname: Maslanka
– volume: 20
  issue: 1
  year: 2018
  ident: 10.1016/j.vaccine.2023.04.056_b0125
  article-title: Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-018-1725-6
  contributor:
    fullname: Davignon
– volume: 16
  start-page: 433
  issue: 3
  year: 2009
  ident: 10.1016/j.vaccine.2023.04.056_b0065
  article-title: Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay
  publication-title: Clin Vaccine Immunol: CVI
  doi: 10.1128/CVI.00364-08
  contributor:
    fullname: de Voer
– volume: 169
  start-page: 1053
  issue: 11
  year: 2015
  ident: 10.1016/j.vaccine.2023.04.056_b0015
  article-title: Inflammatory bowel disease in children and adolescents
  publication-title: JAMA Pediatr
  doi: 10.1001/jamapediatrics.2015.1982
  contributor:
    fullname: Rosen
– volume: 13
  start-page: 243
  issue: 3
  year: 2011
  ident: 10.1016/j.vaccine.2023.04.056_b0140
  article-title: TNF-α Antagonists and Immunization
  publication-title: Curr Infect Dis Rep
  doi: 10.1007/s11908-011-0183-y
  contributor:
    fullname: Visser
– volume: 35
  start-page: 4753
  issue: 36
  year: 2017
  ident: 10.1016/j.vaccine.2023.04.056_b0060
  article-title: Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2017.06.007
  contributor:
    fullname: van Ravenhorst
– volume: 138
  issue: 2
  year: 2016
  ident: 10.1016/j.vaccine.2023.04.056_b0005
  article-title: Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children
  publication-title: Pediatrics
  doi: 10.1542/peds.2016-1209
  contributor:
    fullname: Davies
– volume: 12
  start-page: 540
  issue: 9
  year: 2016
  ident: 10.1016/j.vaccine.2023.04.056_b0030
  article-title: Vaccinating patients with inflammatory bowel disease
  publication-title: Gastroenterol Hepatol (N Y)
  contributor:
    fullname: Reich
– ident: 10.1016/j.vaccine.2023.04.056_b0135
SSID ssj0005319
Score 2.4816244
Snippet Immunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic arthritis...
BackgroundImmunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate vaccine has not been studied in immunocompromised minors with juvenile idiopathic...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 3782
SubjectTerms Adolescent
Adolescents
Age
Anti-TNF agents
Antibodies
Antibodies, Bacterial
Arthritis
Arthritis, Juvenile - drug therapy
Biologicals
Cohort analysis
Conjugates
Drug dosages
Drug therapy
Health care
Humans
Immune system
Immunocompromised
Immunogenicity
Immunogenicity, Vaccine
Immunoglobulin G
Inflammatory bowel disease
Inflammatory bowel diseases
Intestine
Juvenile idiopathic arthritis
Medical research
MenACWY vaccination
Meningococcal Infections - prevention & control
Meningococcal Vaccines - adverse effects
Observational studies
Patients
Pediatrics
Polysaccharides
Prospective Studies
Public health
Safety
Serology
Teenagers
TNF inhibitors
Tumor necrosis factor
Tumor necrosis factor-TNF
Vaccines
Vaccines, Conjugate - adverse effects
SummonAdditionalLinks – databaseName: Public Health Database (Proquest)
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFD6CIdAkhKDcCgMdJLSnpUvrpE54QVPFNCEV7WGD8mTZjqO1gmRbU1B_Gv-Ocxyn3QOXt0ixI8f5cnyu3wF4a_NUC0nWSRIXhktyyshkVkRSkPLg8kLoERc4Tz-NT86Tj7N0Fhxuy5BW2clEL6iL2rKP_JBMAyYqIQS9v7yKuGsUR1dDC43bcGfIBx1Xik9upHgI39iDzIwkSobxbFvBc7gY_NCWQ9cD7h_u2U65h_Wfz6a_6Z7-DDp-CA-C8ohH7dd-BLdc1YO7bTvJdQ_uTUOgvAf7py0l9foAz7YVVssD3MfTLVk1zbnf-u2wLUfqQe8z58f4Il3sHvcYfk0d-09qkp6WFzD58hXJkF6s2AmH4R1xzrUmNSGSZjVr1FWBS106upxXeIM6Ctn5i4sVyVmSSTgv5rVvjGyRcHzhWZb8ZAI_4fW7zwNAU_903zDEk97hEdJudWWiWJuNc5mWx01_rxv0zLlP4Pz4w9nkJApNHyIrctFEudFCG5PGQlpN2os20tksl7mRmUtzl6XOFKIUcjQqEjOOSxJJeTkea5JWLjGxeAo7VV2554BFbApJY0klK5OM7FBraIw0Ms-YJWjUh0H3udVly-2huqS3hQp7pxgfKk4U4aMPWQcKFRSUVvFQdP78b-peByIVpMRSbTHdhzeb2_R_c9BGV65e8RjSsJhBSfbhWQu-zWKFHPKrZC_-_fCXsMsr8Qlucg92muuVe0WqVGNe-__lNzclIUU
  priority: 102
  providerName: ProQuest
Title Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study
URI https://dx.doi.org/10.1016/j.vaccine.2023.04.056
https://www.ncbi.nlm.nih.gov/pubmed/37198018
https://www.proquest.com/docview/2820965101
https://www.proquest.com/docview/2815247877
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGJhAvaJRfhYEOCe1pabM4qZO9lWpTAbWqYIPyZNmJI1JBMq0pqC_8X_vvduc4LUggJF6SNPWpjnv57uzzfcfYqzSJFBc4Own9TFNKTu7pOOWe4Og8mCTjKqAE58l0ML4I386j-Q4btbkwtK3SYX-D6Rat3Z2-G83-ZVH0P_jWlvvzgNvEaMThPTRHFKvdG755N55ud3pwW9-D2nsksE3k6S9631VKEewelRG3pKdUyvrPJupvLqg1RWf77J7zIWHYdPM-2zFlh91uqkquO-zOxMXLO-xw1jBTr4_gfJtotTyCQ5htOatRpvORtsXY3FxoxR-w64mhZZMKQTOlHxx9-gw4f16saO0N3DNBQSkmFSoiStVrUGUGS5UbvCxK-IUxCmjNFxYrhFeEIiiyorL1kFPAAf9iyZWsMOo8quk3G_4HXf0wX8GFkU5gCDg6bXYoVHqzpozdo1q_VzVYwtyH7OLs9Hw09lytBy_lCa-9RCuutI58LlKFTovSwqRxIhItYhMlJo6MznjORRBkoR74OSJRkg8GCkHKhNrnj9huWZXmCYPM15nAtuiJ5WGM089UYxuhRRITOVDQZb3275WXDaWHbPe6LaQbO0n6IP1Qoj50WdwqgfxNNyWanX-JHrRKIx04LCXOcolzB6W67OXma3ytKVajSlOtqA06VkScJLrscaNsm85ycUyPEj_9_349Y3fpk93zJg7Ybn21Ms_Ru6r1C3ar9_MYj2Iu8BiP8Lp5n_D8-nQ6e38DUDssWA
link.rule.ids 314,780,784,4502,12056,12223,21388,24116,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,45585,45679,73745,74014,74302
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFD6CTlwkhKDcCgMOEtrT0mV1Uie8oDFtKrBWFdpYebLsxBGtIBlrC-pP499xjuO0PHB5ixQ7cpwvx-f6HYCXWRprIck6icLccElOEZgkE4EUpDzYNBe6xwXOw1F_cBa9m8QT73Cb-7TKRiY6QZ1XGfvI98g0YKISQtDri28Bd43i6KpvoXEVtpg5PW7B1puj0fjDJslDuNYeZGhEQbQfTjY1PHuz7nedcfC6yx3EHd8pd7H-8-n0N-3TnULHd-C2Vx_xoP7ed-GKLdtwrW4ouWrD9aEPlbdhZ1yTUq928XRTYzXfxR0cb-iqac6t2nOHdUFSG9ofOUPGleli87h78HNo2YNSkfzMeAGH55-QTOnZkt1w6N8Rp1xtUhEmadZihbrMca4LS5fTEn8jj0J2_-JsSZKWpBJO82nlWiNnSEj-7HiW3GSCPyH2q8sEQFP9sF_QR5Re4QHSbjWFoliZtXuZlsdtfy8X6Lhz78PZ8dHp4SDwbR-CTKRiEaRGC21MHAqZadJftJE2S1KZGpnYOLVJbE0uCiF7vTwy_bAgoZQW_b4meWUjE4oH0Cqr0j4CzEOTSxpLSlkRJWSJZobGSCPThHmCeh3oNp9bXdTsHqpJe5spv3eK8aHCSBE-OpA0oFBeRalVD0Un0P-mbjcgUl5OzNUG1R14sb5NfziHbXRpqyWPIR2LOZRkBx7W4FsvVsh9fpXk8b8f_hxuDE6HJ-rk7ej9E7jJq3LpbnIbWovLpX1KitXCPPN_zy83eyXT
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFD6CTkxICEG5rDDgIKE9LW1Wp3XCCxpj1bi0qtDGypNlJ47WCpKxtqD-NP4d5zhOywOXt0ixIyf5fHyu3wF4kSY9LSRZJ1GYGS7JyQMTpyKQgpQHm2RCd7nAeTjqn5xF7ya9ic9_mvu0ylomOkGdlSn7yDtkGjBRCSGok_u0iPGbwavLbwF3kOJIq2-ncR226FQMuw3Yen08Gn_cJHwI1-aDjI4oiA7CyaaepzNrf9cpB7Lb3E3ccZ9yR-s_n1R_00TdiTS4A7e9KomH1b-_C9ds0YQbVXPJVRO2hz5s3oS9cUVQvdrH00291Xwf93C8oa6mObcqLx5WxUlNaH7ibBlXsov14-7Bz6Flb0pJsjTlBRydf0Yyq2dLdsmhf0eccuVJSfikWYsV6iLDuc4tXU4L_I1ICtkVjLMlSV2SUDjNpqVrk5wiofrCcS65ybQVCL1fXVYAmvKH_YI-uvQSD5G-Vl00iqVZu5ppedwC-GqBjkf3PpwNjk-PTgLfAiJIRSIWQWK00Mb0QiFTTbqMNtKmcSITI2PbS2zcsyYTuZDdbhaZfpiTgEryfl-T7LKRCcUDaBRlYXcAs9BkksaSgpZHMVmlqaEx0sgkZs6gbgva9e9WlxXTh6pT4GbKfzvF-FBhpAgfLYhrUCivrlRqiKLT6H9Td2sQKS8z5mqD8BY8X9-m3c4hHF3YcsljSN9iPiXZgocV-NaLFfKAXyV-9O-HP4Nt2jjqw9vR-8dwkxflMt_kLjQWV0v7hHSshXnqN88vwo8qAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Meningococcal+ACWY+conjugate+vaccine+immunogenicity+and+safety+in+adolescents+with+juvenile+idiopathic+arthritis+and+inflammatory+bowel+disease%3A+A+prospective+observational+cohort+study&rft.jtitle=Vaccine&rft.au=Ohm%2C+Milou&rft.au=van+Straalen%2C+Joeri+W.&rft.au=Zijlstra%2C+Marieke&rft.au=de+Joode-Smink%2C+Gerrie&rft.date=2023-06-07&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=41&rft.issue=25&rft.spage=3782&rft.epage=3789&rft_id=info:doi/10.1016%2Fj.vaccine.2023.04.056&rft.externalDocID=S0264410X23004802
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-410X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-410X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-410X&client=summon